The AnyoneNews Briefing — free in your inbox
Top stories, community news, and games. No spam, unsubscribe anytime.
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
This headline comes from the wire. Read the full story at the original publisher:
Continue reading at TechCrunch →The AnyoneNews Briefing
The day's top stories and community happenings — free, no spam.
The VC firm says that AI-native companies are growing faster than any technology, ever.
The startup is working on small, light motors with no rare-earth magnets that are suited for drones, fans, and robots.
At the same time, Disney appears to be exploring new ways to expand its streaming business beyond simply raising subscription prices.
As concern over AI safety and rogue agents continue to make headlines, it’s no surprise that cybersecurity stocks are rising, or that investors are pouring massive amounts of capital into startups trying to build the next generation of security for an AI-native world. We’re even seeing companies like Instinct and Simile bring in nine-figure checks and valuations that wouldn’t have made sense a […]
Readers' desk
Sign in to join the discussion. Free account, real names encouraged, house rules apply.
No comments yet — start the conversation.
